12:00 AM
Aug 04, 2016
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: MicroRNA-3662 (miR-3662)


INDICATION: Acute myelogenous leukemia (AML)

Cell culture and mouse studies suggest miR-3662 could help treat AML. In three human AML cell lines, miR-3662 decreased proliferation and colony formation compared...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >